FMW Media’s New to The Street TV announces the broadcasting of its
business TV show, Friday, July 23, 2021 on Bloomberg
TV at 9:30 PM PT.
New to The Street’s TV line-up features the
following 5-Companies and their businesses representatives:
1). Tonix Pharmaceuticals,
Inc.’s (NASDAQ:TNXP) interview with Mr. Seth Lederman, CEO
2). GlobeX Data Ltd.’s (OTCQB:SWISF)
(CSE:SWIS) (FRA:GDT) interview with Mr. Alain Ghiai, CEO
3). Cryptocurrency, Kylin Network’s
(CRYPTO:KYL)($KYL) interview with Mr. Dylan Dewdney, Project Lead
& Co-Founder
4). Cryptocurrency, Finxflo’s
($FXF) interview with Mr. James Gillingham, CEO
5). Cryptocurrency, MahaDAO’s ($MAHA) interview
with Mr. Steven Enamakel, Creator.
Tonix Pharmaceuticals, Inc.’s (NASDAQ:TNXP)
CEO, Seth Lederman, talks to “New To The Street” TV about their
Company’s pharmaceutical products, and his further discussion about
their development and FDA phase 3 on its Fibromyalgia drug.
Mr. Lederman talks about the importance of ‘HOW’
this Fibromyalgia drug helps patients sleep better without
pain.
GlobeX Data Ltd’s., (OTCQB:SWISF) (CSE:SWIS)
(FRA:GDT) CEO, Alian Ghiai, talks to “New To The Street” TV about
their business and their futures plans for the Company.
He provides in-depth discussion of the Company’s successful secure
and encrypted software solutions, SekurSafe® and Sekur®.
He further talks about keeping business communications and data
safe while utilizing Swiss Privacy Laws.
New to The Street TV welcomes Mr. Dylan Dewdney,
Project Lead & Co-Founder at Kylin Network’s
(CRYPTO:KYL)($KYL). Mr. Dewdney explains Kylin Network’s business
strategy which utilizes unique analytical tools, decentralized data
protocols and data exchange / pricing. He gives in-depth discussion
to our TV audience about the architecture of the $KYL token.
Mr. James Gillingham, CEO,
FINXFLO ($FXF) (CRYPTO: FXF), the world's first
hybrid DeFi/CeFi liquidity aggregator, appears on New to The Street
TV. Mr. Gillingham shares details around a number of FXF’s recent
announcements, whereas FXF continues to grow its
platform to provide a seamless and user-friendly
cryptocurrency trading experience. And, he talks to viewers about
their “KYT” (Know Your Transaction), explaining how the “KYT”
system works for trading and best price for crypto platforms.
Cryptocurrency, MahaDAO’s ($MAHA) creator Mr.
Steven Enamakel talks to the New to The Street views about their
ARTH ($ARTH) coin. He explains the functionality of this new kind
of money that actual maintains it buying power no matter “WHAT”
happens in the market place. Mr. Enamakel further gives intricate
details on the ARTH coin design and how it works with the MAHA
token to maintain wealth, whereas the value of your money never
drops.
About Tonix Pharmaceuticals Holding
Corp. (NASDAQ: TNXP):
Tonix is a clinical-stage biopharmaceutical
company focused on discovering, licensing, acquiring and developing
small molecules and biologics to treat and prevent human disease
and alleviate suffering. Tonix's portfolio is primarily composed of
the central nervous system (CNS) and immunology product candidates.
The CNS portfolio includes both small molecules and biologics to
treat pain, neurologic, psychiatric and addiction conditions.
Tonix's lead CNS candidate, TNX-102 SL1, is in mid-Phase 3
developments for the management of fibromyalgia, and positive data
on the RELIEF Phase 3 trial were recently reported. The Company
expects interim data from a second Phase 3 study, RALLY, in the
third quarter of 20212 and top-line data in the fourth quarter
of 2021. The immunology portfolio includes vaccines to prevent
infectious diseases and biologics to address immunosuppression,
cancer, and autoimmune diseases. Tonix's lead vaccine candidate,
TNX-1800, is a live replicating vaccine based on the horsepox viral
vector platform to protect against COVID-19, primarily by eliciting
a T cell response. Tonix reported positive efficacy data from
animal studies of TNX-1800 in the first quarter of 2021. TNX-801,
live horsepox virus vaccine for percutaneous administration, is in
development to protect against smallpox and monkeypox
– www.tonixpharma.com
1TNX-102 SL is an investigational new drug and has
not been approved for any indication. 2Pending agreement from FDA
on statistical analysis plan
About GlobeX Data Ltd. (OTCQB:SWISF)
(CSE:SWIS) (FRA:GDT):
GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS)
(FRA:GDT) is a Cybersecurity and Internet Privacy provider of Swiss
hosted solutions for secure communications and secure data
management. The Company distributes a suite of secure messaging
applications, encrypted e-mails, secure communications and secure
data management tools, using Swiss privacy laws, proprietary
technology and its own independent platform, away from big techs
hosting platforms. GlobeX Data Ltd. sells its products through its
approved wholesalers and distributors, and telecommunications
companies worldwide. GlobeX Data Ltd. serves consumers, businesses
and governments worldwide - https://globexdata.com. Sekur® is a
Swiss secure communications application offering secure and private
messaging, emails, voice messages, self-deleting messages, and file
transfers from any mobile device, tablet, or desktop. Sekur users
can communicate with Sekur and with non-Sekur users, through its
unique Chat-By-Invites feature and Sekur Send email system. All
data traffic stay in GlobeX Data's Swiss hosted servers, using its
proprietary HeliX technology, military grade encryption and
benefiting from Swiss Privacy Laws – https://sekur.com. Twitter:
@globexdata.
About FINXFLO:
Co-founded by leaders in their respective niches,
FINXFLO is a platform that focuses on changing the cryptocurrency
market through innovation. As the world's first hybrid DeFi/CeFi
liquidity and protocol aggregator, FINXFLO brings a one-stop
solution for all cryptocurrency traders and investors. Using only
one account with one KYC, our users are now able to utilize
liquidity from 25+ CeFi and DeFi platforms through a single user
interface. In simple terms, FINXFLO blends all the upsides of DeFi
and CeFi ecosystems to produce the ultimate product-
finxflo.com.
Kylin
Networks (CRYPTO:KYL)($KYL):
Kylin Networks (CRYPTO:KYL)($KYL) aim to
build a cross-chain platform, powering the data economy on Polkadot
by offering any applications and blockchain instantaneously but
reliable and valid on/off-chain market date and social data. Kylin
Network represents extensibility and a synergistic increase to the
off-chain workers capability as it will provide not only access,
management, insights, coordination to a greater array of data
sources, but bolster validity and decentralization of the data
sources themselves. Using the Polkadot/Substrate framework, Kylin
Network can ensure cost-effective solution that data customers and
Dapp Builders can use over centralized sources. The architecture at
Kylin Network includes 4-major components, Kylin Data Analytics,
Kylin Data Oracle, Kylin Data Marketplace, and Kylin Token KYL
($KYL)
- https://kylin.network/ & https://www.kylin.network/video/kylin.mp4
About MahaDAO’s ($MAHA):
MAHA is the governance and utility token that
regulates the ARTH valuecoin and keeps the protocol decentralised.
Decentralisation is one of the most important features that gives
value to the ARTH token. The more decentralised ARTH becomes, the
easier it becomes for users to trust the functionalities governing
ARTH. MAHA token holders have an influence on ARTH in a number of
different scenarios. MAHA token holders can govern, stability fees,
protocol direction & strategy and improvement proposals that
optimize the protocol. Community members use the MAHA token to vote
on key aspects of the ecosystem in order to collectively manage the
parameters that keep ARTH stable and in check. Using democratic
frameworks such as governance portals, forums & the power of
social discourse, growth is driven by the community and for the
community- https://mahadao.com/.
About FMW Media:
FMW Media operates one of the longest-running U.S
and International sponsored and Syndicated Nielsen Rated
programming T.V. brands "New to the Street," and its blockchain
show "Exploring The Block." Since 2009, these brands run
biographical interview segment shows across major U.S. Television
networks. The TV platforms reach over 540 million homes both in the
US and international markets. The New to The Street / Newsmax TV
show is syndicated on Sundays at 10 AM EST. FMW is also one of the
nation's largest buyers of linear Television long and short
form- https://www.newsmaxtv.com/Shows/New-to-the-Street & https://www.newtothestreet.com/
Forward-Looking Statements
Disclaimer: This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. In some cases, you can identify
forward-looking statements by the following words: "anticipate,"
"believe," "continue," "could," "estimate," "expect," "intend,"
"may," "ongoing," "plan," "potential," "predict," "project,"
"should," "will," "would," or the negative of these terms or other
comparable terminology, although not all forward-looking statements
contain these words. Forward-looking statements are not a guarantee
of future performance or results, and will not necessarily be
accurate indications of the times at, or by, which such performance
or results achieved. This press release should be considered in
light of all filings of the Company contained in the Edgar Archives
of the Securities and Exchange Commission at www.sec.gov.
FMW Media Contact: Bryan Johnson +1 (631) 766-7462
Bryan@NewToTheStreet.com
And
“New to The Street” Business Development office
Support@NewtoTheStreet.com 1-516-696-5900
Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Sep 2023 to Sep 2024